Vagus Nerve Stimulation and Myocardial Ischemia‐Reperfusion Injury Background Low‐
level vagus nerve stimulation (LL‐VNS) has been demonstrated to protect myocardium …

The morbidity and mortality of patients with ischemic cardiomyopathy resulted from
ischemia/reperfusion injury are very high. The present study investigates whether our …

Relaxin is safe and efficient to use for treating acute heart failure. However, the
electrophysiological and arrhythmogenic effects of relaxin in an experimental healing …

To achieve reliable experimental data, the side-effects of anesthetics should be eliminated.
Since anesthetics exert a variety of effects on hemodynamic data and incidence of …

Noninvasive magnetic stimulation has been widely used in autonomic disorders in the past
few decades, but few studies has been done in cardiac diseases. Recently, studies showed …

Lumbrokinase, a novel antithrombotic agent, purified from the earthworm Lumbricus
rubellus, has been clinically used to treat stroke and cardiovascular diseases. However …

c-Kitpos cardiac progenitor cells (CPCs) represent a successful approach in healing the
infarcted heart and rescuing its mechanical function, but electrophysiological consequences …

The unmet clinical need for myocardial salvage during ischaemia–reperfusion injury
requires the development of new techniques for myocardial protection. In this study the …

Although cardio-vascular incidents and sudden cardiac death (SCD) are among the leading
causes of premature death in the general population, the origins remain unidentified in …

Available inotropic pharmacotherapy for acute heart failure (HF) remains largely ineffective
at ameliorating marked impairments in contractile function. Nitroxyl (HNO), the redox sibling …